Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.3718 EUR
−1.12 B EUR
4.00 B EUR
486.97 M
About Elanco Animal Health Incorporated
Sector
Industry
CEO
Jeffrey N. Simmons
Website
Headquarters
Greenfield
Founded
1954
FIGI
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
LLY4841184
Elanco Animal Health Incorporated 6.65% 28-AUG-2028Yield to maturity
5.94%
Maturity date
Aug 28, 2028
ELAN4667244
Elanco Animal Health Incorporated 6.65% 28-AUG-2028Yield to maturity
4.99%
Maturity date
Aug 28, 2028
Explore more bonds
Frequently Asked Questions
The current price of A2N6BH is 11.7560 EUR — it has increased by 0.82% in the past 24 hours. Watch Elanco Animal Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Elanco Animal Health, Inc. stocks are traded under the ticker A2N6BH.
A2N6BH stock has risen by 3.43% compared to the previous week, the month change is a 1.22% rise, over the last year Elanco Animal Health, Inc. has showed a −13.38% decrease.
We've gathered analysts' opinions on Elanco Animal Health, Inc. future price: according to them, A2N6BH price has a max estimate of 20.21 EUR and a min estimate of 13.48 EUR. Watch A2N6BH chart and read a more detailed Elanco Animal Health, Inc. stock forecast: see what analysts think of Elanco Animal Health, Inc. and suggest that you do with its stocks.
A2N6BH reached its all-time high on Nov 12, 2024 with the price of 13.8100 EUR, and its all-time low was 11.0240 EUR and was reached on Dec 23, 2024. View more price dynamics on A2N6BH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
A2N6BH stock is 2.95% volatile and has beta coefficient of 1.50. Track Elanco Animal Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elanco Animal Health, Inc. there?
Today Elanco Animal Health, Inc. has the market capitalization of 5.67 B, it has decreased by −2.66% over the last week.
Yes, you can track Elanco Animal Health, Inc. financials in yearly and quarterly reports right on TradingView.
Elanco Animal Health, Inc. is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
A2N6BH earnings for the last quarter are 0.12 EUR per share, whereas the estimation was 0.11 EUR resulting in a 6.20% surprise. The estimated earnings for the next quarter are 0.15 EUR per share. See more details about Elanco Animal Health, Inc. earnings.
Elanco Animal Health, Inc. revenue for the last quarter amounts to 925.09 M EUR, despite the estimated figure of 930.73 M EUR. In the next quarter, revenue is expected to reach 976.90 M EUR.
A2N6BH net income for the last quarter is 326.92 M EUR, while the quarter before that showed −46.68 M EUR of net income which accounts for 800.35% change. Track more Elanco Animal Health, Inc. financial stats to get the full picture.
No, A2N6BH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 7, 2025, the company has 9.80 K employees. See our rating of the largest employees — is Elanco Animal Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Elanco Animal Health, Inc. EBITDA is 828.09 M EUR, and current EBITDA margin is 23.09%. See more stats in Elanco Animal Health, Inc. financial statements.
Like other stocks, A2N6BH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elanco Animal Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.